Skip to main content
. 2020 Mar 23;26:e920778-1–e920778-10. doi: 10.12659/MSMBR.920778

Table 2.

The relation between GLUT-1 expression and clinicopathological parameters in 190 advanced gastric cancer cases.

Clinicopathological parameters GLUT-1 expression P-value
Negative (score 0)
n=74
Positive (score 1~2)
n=116
Gender 0.191
 Male 49 (66.2%) 87 (75.0%)
 Female 25 (33.8%) 29 (25.0%)
Age (year) 63±14 66±11 0.099a
Tumor diameter (cm) 4.78±2.35 5.68±2.48 0.007a,*
Tumor localization 0.039*
 Upper 9 (12.2%) 32 (27.6%)
 Middle 14 (18.9%) 16 (13.8%)
 Lower 51 (68.9%) 68 (58.6%)
pT 0.382b
 T2 14 (18.9%) 14 (12.1%)
 T3 1 (1.4%) 3 (2.6%)
 T4 (T4a, T4b) 59 (79.7%) 99 (85.3%)
pN 0.328
 N0 9 (12.2%) 26 (22.4%)
 N1 13 (17.5%) 21 (18.1%)
 N2 21 (28.4%) 29 (25.0%)
 N3 (N3a, N3b) 31 (41.9%) 40 (34.5%)
M 0.012b,*
 M0 72 (97.3%) 101 (87.1%)
 M1 2 (2.7%) 15 (12.9%)
TNM stage 0.233b
 IB 3 (4.0%) 7 (6.0%)
 IIA, IIB 15 (20.3%) 23 (19.8%)
 IIIA, IIIB, IIIC 54 (73.0%) 75 (64.7%)
 IV 2 (2.7%) 11 (9.5%)
Histology <0.001b,*
 Well differentiated 8 (10.8%) 20 (17.3%) <0.001b,c,*
 Moderately differentiated 16 (21.6%) 57 (49.1%)
 Poorly differentiated 43 (58.1%) 34 (29.3%)
 Signet-ring cell 6 (8.1%) 3 (2.6%)
 Mucinous 1 (1.4%) 2 (1.7%)
Lauren type <0.001*
 Intestinal 24 (32.4%) 77 (66.4%)
 Diffuse 50 (67.6%) 39 (33.6%)
Venous invasion 0.085
 Positive 55 (74.3%) 98 (84.5%)
 Negative 19 (25.7%) 18 (15.5%)
Lymphatic invasion 0.100
 Positive 65 (87.8%) 91 (78.4%)
 Negative 9 (12.2%) 25 (21.6%)
Perineural invasion 0.265
 Positive 50 (67.6%) 87 (75.0%)
 Negative 24 (32.4%) 29 (25.0%)
a

Mann-Whitney U test;

b

Fisher’s exact test;

c

Comparison of different grade in adenocarcinoma.

*

P<0.05.

GLUT-1 – glucose transporter-1.